AtriCure, Inc. (NASDAQ:ATRC)
CAPS Rating:
The Company develops, manufactures and sells innovative surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues.
The Company develops, manufactures and sells innovative surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues.
Recs
T3A C<$10 and C>maxH3.1 and s50A&20.1V